Active Ingredients Section
DRUG FACTS
CAPSAICIN 0.025%
The following Structured Product Label (SPL) was submitted to the FDA by Toqara, Inc. for the product Rezil (NDC 76468-121). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients section, purpose section, keep out of reach of children section, indications and uses section, warnings section, dosage and administration section, inactive ingredients section, questions or comments section, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
DRUG FACTS
CAPSAICIN 0.025%
TOPICAL ANALGESIC
KEEP AWAY FROM CHILDREN.
USES: FOR TEMPORARY RELIEF OF MINOR ACHES, AND PAINS OF MUSCLES AND JOINTS ASSOCIATED WITH ARTHRITIS, STRAINS, SPRAINS, AND BRUISES.
WARNINGS: FOR EXTERNAL USE ONLY. AVOID CONTACT WITH EYES. IF CONDITION WORSEN, OR IF SYMPTOMS PERSIST FOR MORE THAN 7 DAYS, OR CLEAR UP AND OCCUR AGAIN WITHIN A FEW DAYS, DISCONTINUE USE A CONSULT A PHYSICIAN. DO NOT APPLY TO WOUNDS OR DAMAGED SKIN. DO NOT BANDAGE TIGHTLY.
DIRECTIONS: ADULTS AND CHILDREN OVER 6 YEARS OF AGE - APPLY TO AFFECTED AREA AND RUB GENTLY UNTIL ABSORBED. DO NOT USE MORE THAN 3 OR 4 TIMES DAILY.
ISOHEXADECANE, MINERAL OIL AND DIMETHICONE
QUESTIONS OR COMMENTS? 1-800-000-0000 OR GO TO WWW.TOQARA.COM
OTHER INFORMATION: STORE AT ROOM TEMPERATURE
REZIL PAIN RELIEF LOTION ROLL-ON
PENETRATING PAIN RELIEF FOR ARTHRITIS, STRAINS, SPRAINS AND BRUISES
NET 3 FLUID OZ./88ML MANUFACTURED FOR TOQARA, INC. LAKEWOOD, CO 80214
* Please review the disclaimer below.